Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway

PLoS Biol. 2017 Jan 26;15(1):e2000731. doi: 10.1371/journal.pbio.2000731. eCollection 2017 Jan.

Abstract

Lung squamous cell carcinoma (SqCC), the second most common subtype of lung cancer, is strongly associated with tobacco smoking and exhibits genomic instability. The cellular origins and molecular processes that contribute to SqCC formation are largely unexplored. Here we show that human basal stem cells (BSCs) isolated from heavy smokers proliferate extensively, whereas their alveolar progenitor cell counterparts have limited colony-forming capacity. We demonstrate that this difference arises in part because of the ability of BSCs to repair their DNA more efficiently than alveolar cells following ionizing radiation or chemical-induced DNA damage. Analysis of mice harbouring a mutation in the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a key enzyme in DNA damage repair by nonhomologous end joining (NHEJ), indicated that BSCs preferentially repair their DNA by this error-prone process. Interestingly, polyploidy, a phenomenon associated with genetically unstable cells, was only observed in the human BSC subset. Expression signature analysis indicated that BSCs are the likely cells of origin of human SqCC and that high levels of NHEJ genes in SqCC are correlated with increasing genomic instability. Hence, our results favour a model in which heavy smoking promotes proliferation of BSCs, and their predilection for error-prone NHEJ could lead to the high mutagenic burden that culminates in SqCC. Targeting DNA repair processes may therefore have a role in the prevention and therapy of SqCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cell Death
  • Cell Separation
  • DNA Breaks, Double-Stranded
  • DNA Damage*
  • DNA End-Joining Repair*
  • Epithelial Cells / cytology
  • Epithelial Cells / ultrastructure
  • Humans
  • Lung / cytology*
  • Lung Neoplasms / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • Neoplasms, Squamous Cell / pathology
  • Pulmonary Alveoli / cytology
  • Smoking / adverse effects
  • Stem Cells / cytology*
  • Trachea / cytology

Substances

  • Biomarkers

Grants and funding

Australian Post-graduate Award. Received by CEW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Victorian State Government Operational Infrastructure Support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Health and Medical Research Council (grant number 1058892 and 1054618). Received by GKS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Victorian Cancer Agency (grant number TS10-18). Received by MLAL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Viertel Charitable Foundation Senior Medical Research Fellowship. Recevied by MLAL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CRC Cancer Therapeutics PhD Top-up Scholarship. Received by CEW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Australian Government NHMRC IRIISS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.